A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

BMC Ear, Nose and Throat Disorders

Volumn 11, Issue 1, 2011, Pages

  Suckfüll, Markus ^a   Althaus, Michael ^b   Ellers Lenz, Barbara ^b   Gebauer, Alexander ^b   Görtelmeyer, Roman ^b   Jastreboff, Pawel J ^c   Moebius, Hans J ^b   Rosenberg, Tanja ^b   Russ, Hermann ^b   Wirth, Yvonne ^b   Krueger, Hagen ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERAMEXANE; PLACEBO;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; TINNITUS; VERTIGO;

EID: 79551545294     PISSN: None     EISSN: 14726815     Source Type: Journal    
DOI: 10.1186/1472-6815-11-1     Document Type: Article

References (24)

1. Tinnitus in der Bundesrepublik Deutschland - eine repräsentative epidemiologische Studie. M Pilgram R Rychlik H Lebisch H Siedentop G Goebel D Kirchhoff, HNO aktuell 1999 7 261 265
2. Tinnitus: neurobiological substrates. JJ Eggermont, Drug Discov Today 2005 10 1283 1290 10.1016/S1359-6446(05)03542-7 16214672
3. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. AH Lockwood RJ Salvi ML Coad ML Towsley DS Wack BW Murphy, Neurology 1998 50 114 120 9443467
4. Tinnitus severity, loudness, and depression. RL Folmer SE Griest MB Meikle WH Martin, Otolaryngol Head Neck Surg 1999 121 48 51 10.1016/S0194- 5998(99)70123-3 10388877
5. Psychoacoustic measures of tinnitus. JA Henry MB Meikle, J Am Acad Audiol 2000 11 138 155 10755810
6. The perceived severity of tinnitus; some observations concerning a large population of tinnitus clinic patients. MB Meikle J Vernon RM Johnson, Otolaryngol Head Neck Surg 1984 92 689 696 6440089
7. When tinnitus loudness and annoyance are discrepant: audiological characteristics and psychological profile. W Hiller G Goebel, Audiol Neurootol 2007 12 391 400 10.1159/000106482 17664870
8. N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. AS Basile JM Huang C Xie D Webster C Berlin P Skolnick, Nat Med 1996 2 1338 1343 10.1038/nm1296-1338 8946832
9. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. AB Elgoyhen DE Vetter E Katz CV Rothlin SF Heinemann J Boulter, Proc Natl Acad Sci USA 2001 98 3501 3506 10.1073/pnas.051622798 11248107
10. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. AB Elgoyhen DS Johnson J Boulter DE Vetter S Heinemann, Cell 1994 79 705 715 10.1016/0092-8674(94)90555-X 7954834
11. The nicotinic receptor of cochlear hair cells: a possible pharmacotherapeutic target? AB Elgoyhen E Katz PA Fuchs, Biochem Pharmacol 2009 78 712 719 10.1016/j.bcp.2009.05.023 19481062
12. Objective evidence of peripheral auditory disorders in learning-impaired children. E Veuillet F Bazin L Collet, J Audiol Med 1999 8 18 29
13. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. CG Parsons W Danysz A Bartmann P Spielmanns T Frankiewicz M Hesselink B Eilbacher G Quack, Neuropharmacology 1999 38 85 108 10.1016/S0028-3908(98)00161-0 10193901
14. Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by Neramexane, an open channel blocker of N methyl-D aspartate receptors. PV Plazas J Savino S Kracun ME Gomez-Casati E Katz CG Parsons NS Millar AB Elgoyhen, Eur J Pharmacol 2007 566 11 19 10.1016/j.ejphar.2007.03.026 17466293
15. Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists. W Danysz CG Parsons A Jirgensons V Kauss J Tillner, Curr Pharm Des 2002 8 835 843 10.2174/1381612024607117 11945134
16. The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. G Rammes R Rupprecht U Ferrari W Zieglgänsberger CG Parsons, Neurosci Lett 2001 306 81 84 10.1016/S0304-3940(01)01872-9 11403963
17. Treatments for tinnitus. W Noble, Trends Amplif 2008 12 236 241 10.1177/1084713808320552 18635586
18. Der Tinnitus-Beeinträchtigungs-Fragebogen (TBF-12). bersetzung und Adaption. KV Greimel M Leibetseder J Unterrainer E Biesinger K Albegger, Verhaltenstherapie und Verhaltensmedizin 2000 21 39 49
19. Intercultural validation of the Tinnitus Handicap Inventory 12 (THI-12). US Korbel R Görtelmeyer E Elkin, 4th Tinnitus Research Initiative Meeting 2010 Dallas, Texas
20. The hospital anxiety and depression scale. AS Zigmond RP Snaith, Acta Psychiatr Scand 1983 67 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820
21. AWMF online: Leitlinien der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie: Tinnitus. E Biesinger G Hesse B Mazurek HP Zenner T Brusis G Goebel B Kröner-Herwig O Michel W Arnold, http://www.uni-duesseldorf.de/AWMF/ll/017-064.htm
22. Tinnitus coping style and its relationship to tinnitus severity and emotional distress. RJ Budd R Pugh, J Psychosomatic Res 1996 41 327 335 10.1016/S0022-3999(96)00171-7 (Pubitemid 26395161)
23. Consensus for tinnitus patient assessment and treatment outcome measurement. Tinnitus Research Initiative Meeting: XX-YY July 2006; Regensburg, Germany. Prog Brain Res, Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, Del Bo L, De Ridder D, Diges I, Elbert T, Flor H, Herraiz C, Ganz Sanchez T, Eichhammer P, Figueiredo R, Hajak G, Kleinjung T, Landgrebe M, Londero A, Lainez MJ, Mazzoli M, Meikle MB, Melcher J, Rauschecker JP, Sand PG, Struve M, Van de Heyning P, Van Dijk P, Vergara R, 2007 166 525 36
24. Tinnitus treatment with memantine. RR Figueiredo B Langguth P Mello de Oliveira A Aparecida de Azevedo, Otolaryngol Head Neck Surg 2008 138 492 496 10.1016/j.otohns.2007.11.027 18359360